[en] Herbal remedies used in traditional medicine often contain several compounds combined in order to potentiate their own intrinsic properties. However, herbs can sometimes cause serious health troubles. In Belgium, patients who developed severe aristolochic acid nephropathy ingested slimming pills containing root extracts of an Aristolochia species, as well as the bark of Magnolia officinalis. The goal of the study was to evaluate, on a human renal cell line, Aristolochia and Magnolia extracts for their cytotoxicity by a resazurin cell viability assay, and their genotoxicity by immunodetection and quantification of the phosphorylated histone γ-H2AX. The present study also sought to assess the mutagenicity of these extracts, employing an OECD recognized test, the Ames test, using four Salmonella typhimurium strains with and without a microsomial fraction. Based on our results, it has been demonstrated that the Aristolochia–Magnolia combination (aqueous extracts) was more genotoxic to human kidney cells, and that this combination (aqueous and methanolic extracts) was more cytotoxic to human kidney cells after 24 and 48 h. Interestingly, it has also been shown that the Aristolochia–Magnolia combination (aqueous extracts) was mutagenic with a TA98 Salmonella typhimurium strain in the presence of a microsomial liver S9 fraction. This mutagenic effect appears to be dose-dependent.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Poivre, Mélanie
Antoine, Marie-Hélène
Kryshen, Kirill
Atsapkina, Anastasia
Shikov, Alexander N.
Twyffels, Laure
NACHTERGAEL, Amandine ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chimie thérapeutique et Pharmacognosie
DUEZ, Pierre ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chimie thérapeutique et Pharmacognosie
Nortier, Joëlle
Language :
English
Title :
Assessment of the Cytotoxicity, Mutagenicity, and Genotoxicity of Two Traditional Chinese Herbs: Aristolochia baetica and Magnolia officinalis
Das S. Thakur S. Korenjak M. Sidorenko V.S. Chung F.F. Zavadil J. Aristolochic acid-associated cancers: A public health risk in need of global action Nat. Rev. Cancer 2022 22 576 591 10.1038/s41568-022-00494-x 35854147
Holanda D.M. Yiannikouris A. Kim S.W. Investigation of the Efficacy of a Postbiotic Yeast Cell Wall-Based Blend on Newly-Weaned Pigs under a Dietary Challenge of Multiple Mycotoxins with Emphasis on Deoxynivalenol Toxins 2020 12 504 10.3390/toxins12080504 32781569
Gruber-Dorninger C. Jenkins T. Schatzmayr G. Global mycotoxin occurrence in feed: A ten-year survey Toxins 2019 11 375 10.3390/toxins11070375 31252650
Poivre M. Nachtergael A. Bunel V. Okusa P. Duez P. Chapter 9: Genotoxicity and Carcinogenicity of Herbal Products Toxicology of Herbal Products Pelkonen O. Duez P. Vuorela P. Vuorela H. Springer Cham, Switzerland 2017 179 215
Jing Y.J. Ni J.W. Ding F.H. Fang Y.H. Wang X.Q. Wang H.B. Chen X.N. Chen N. Zhan W.W. Lu L. et al. p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE−/− mice Kidney Int. 2016 89 439 449 10.1038/ki.2015.287 26466319
Cunha R.S.D. Santos A.F. Barreto F.C. Stinghen A.E.M. How do uremic toxins affect the endothelium? Toxins 2020 12 412 10.3390/toxins12060412
Vanherweghem J.L. Tielemans C. Abramowicz D. Depierreux M. Vanhaelen-Fastre R. Vanhaelen M. Jadoul M. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs Lancet 1993 341 387 391 10.1016/0140-6736(93)92984-2
Depierreux M. Van Damme B. Houte K.V. Vanherweghem J.L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs AJKD 1994 24 172 180 10.1016/S0272-6386(12)80178-8
Jadot I. Declèves A.E. Nortier J. Caron N. An integrated view of aristolochic acid nephropathy: Update of the literature Int. J. Mol. Sci. 2017 18 297 10.3390/ijms18020297
Vanhaelen M. Vanhaelen-Fastre R. But P. Vanherweghem J.-L. Identification of aristolochic acid in Chinese herbs Lancet 1994 343 174 10.1016/S0140-6736(94)90964-4
Kang Y.C. Chen M.H. Lin C.Y. Lin C.Y. Chen Y.T. Aristolochic acid-associated urinary tract cancers: An updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies Ther. Adv. Drug Saf. 2021 12 2042098621997727 10.1177/2042098621997727
Bunel V. Souard F. Antoine M.H. Stévigny C. Nortier J. Nephrotoxicity of Natural Products: Aristolochic Acid and Fungal Toxins. Comprehensive Toxicology 3rd ed. Rath T. IntechOpen London, UK 2018 Volume 14 340 379
Anttila A. Bhat R.V. Bond J.A. Borghoff S.J. Bosch F.X. Carlson G.P. Castegnaro M. Cruzan G. Gelderblom W.C. Hass U. et al. IARC monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene IARC Monographs on the Evaluation of Carcinogenic Risks to Humans IARC Press Lyon, France 2002 Volume 82 69 129
Bara T. Jr. Gurzu S. Sugimura H. Bara T. Beleaua M.A. Jung I. A systematic review of the possible carcinogenic role of the aristolochic acid Rom. J. Morphol. Embryol. 2017 58 41 44 28523296
Debelle F.D. Vanherweghem J.L. Nortier J.L. Aristolochic acid nephropathy: A worldwide problem Kidney Int. 2008 74 158 169 10.1038/ki.2008.129 18418355
Jelaković B. Dika Ž. Arlt V.M. Stiborova M. Pavlović N.M. Nikolić J. Colet J.M. Vanherweghem J.L. Nortier J.L. Balkan endemic nephropathy and the causative role of aristolochic acid J. Sem. Nephrol. 2019 39 284 296 10.1016/j.semnephrol.2019.02.007 31054628
Zhang J. Chan C.K. Ham Y.H. Chan W. Identifying Cysteine, N-Acetylcysteine, and Glutathione-Conjugates as Novel Metabolites of Aristolochic Acid I: Emergence of a New Detoxification Pathway Chem. Res. Toxicol. 2020 33 1374 1381 10.1021/acs.chemrestox.9b00488 32048847
Nachtergael A. Poivre M. Belayew A. Duez P. In vitro genotoxicity tests point to an unexpected and harmful effect of a Magnolia and Aristolochia association J. Ethnopharmacol. 2015 174 178 186 10.1016/j.jep.2015.07.045 26278811
Kong Z.L. Tzeng S.C. Liu Y.C. Cytotoxic neolignans: An SAR study Bioorg. Med. Chem. Lett. 2005 15 163 166 10.1016/j.bmcl.2004.10.011 15582432
Poivre M. Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents J. Zhejiang Univ. Sci. B 2017 18 194 214 28271656
Yan R. Wang W. Guo J. Liu H. Zhang J. Yang B. Studies on the Alkaloids of the Bark of Magnolia officinalis: Isolation and On-line Analysis by HPLC-ESI-MSn Molecules 2013 18 7739 7750 10.3390/molecules18077739
Guo Z.F. Wang X.B. Luo J.G. Luo J. Wang J.S. Kong L.Y. A novel aporphine alkaloid from Magnolia officinalis Fitoterapia 2011 82 637 641 10.1016/j.fitote.2011.01.021
Dharmananda S. Safety Issues Affecting Chinese Herbs: Magnolia Alkaloids Institute for Traditional Medicine Portland, OR, USA 2002 Available online: http://www.itmonline.org/arts/magsafe.htm (accessed on 15 November 2022)
Kuo L.J. Yang L.X. γ-H2AX-a novel biomarker for DNA double-strand breaks In Vivo 2008 22 305 309
Valdiglesias V. Giunta S. Fenech M. Neri M. Bonassi S. γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies Mutat. Res. 2013 753 24 40 10.1016/j.mrrev.2013.02.001 23416207
Alonso-Jauregui M. González-Peñas E. López de Cerain A. Vettorazzi A. Genotoxicity of 12 Mycotoxins by the SOS/umu Test: Comparison of Liver and Kidney S9 Fraction Toxins 2022 14 400 10.3390/toxins14060400 35737061
Estevez P. Sibat M. Leão-Martins J.M. Tudó A. Rambla-Alegre M. Aligizaki K. Diogène J. Gago-Martinez A. Hess P. Use of Mass Spectrometry to Determine the Diversity of Toxins Produced by Gambierdiscus and Fukuyoa Species from Balearic Islands and Crete (Mediterranean Sea) and the Canary Islands (Northeast Atlantic) Toxins 2020 12 305 10.3390/toxins12050305 32392808
Xue L. Zhang J. Shen H. Ai L. Wu R. A randomized controlled pilot study of the effectiveness of magnolia tea on alleviating depression in postnatal women Int. J. Food Sci. Nutr. 2020 8 1554 1561 10.1002/fsn3.1442 32180964
Najafi M.B.H. Pezeshki P. Bacterial mutation; types, mechanisms and mutant detection methods: A review Eur. Sci. J. 2013 4 1857 7431
OECD Guidance Document on Revisions to OECD Genetic Toxicology Test Guidelines Genetic Toxicology Guidance Document; OECD Paris, France 31 August 2015
Maron D.M. Ames B.N. Revised methods for the Salmonella mutagenicity test Mutat. Res. 1983 113 173 215 10.1016/0165-1161(83)90010-9
Liman R. Akyıl D. Eren Y. Konuk M. Testing of the mutagenicity and genotoxicity of metolcarb by using both Ames/Salmonella and Allium test Chemosphere 2010 80 1056 1061 10.1016/j.chemosphere.2010.05.011
Rédei G.P. Encyclopedia of Genetics, Genomics, Proteomics, and Informatics Springer Science & Business Media Dordrecht, The Netherlands 2008
Stiborová M. Mareîs J. Frei E. Arlt V.M. Martínek V. Schmeiser H.H. The human carcinogen aristolochic acid I is activated to form DNA adducts by human NAD (P) H: Quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases Environ. Mol. Mutagen. 2011 52 448 459 10.1002/em.20642
Sidorenko V.S. Attaluri S. Zaitseva I. Iden C.R. Dickman K.G. Johnson F. Grollman A.P. Bioactivation of the human carcinogen aristolochic acid Carcinogenesis 2014 35 1814 1822 10.1093/carcin/bgu095
Afaq F. Natural agents: Cellular and molecular mechanisms of photoprotection Arch. Biochem. Biophys. 2011 508 144 151 10.1016/j.abb.2010.12.007
Hazra B. Ghosh S. Kumar A. Pandey B.N. The prospective role of plant products in radiotherapy of cancer: A current overview Front. Pharmacol. 2012 2 94 10.3389/fphar.2011.00094 22291649
Cui W. Wang Y. Chen Q. Sun W. Cai L. Tan Y. Kim K.S. Kim K.H. Kim Y.H. Magnolia extract (BL153) ameliorates kidney damage in a high fat diet-induced obesity mouse model Oxid. Med. Cell. Longev. 2013 2013 367040 10.1155/2013/367040 24381715
Au C.K. Chan C.K. Tung K.K. Zhang J. Chan W. Quantitation of DNA Adducts of Aristolochic Acids in Repair-Deficient Cells: A Mechanistic Study of the DNA Repair Mechanism Chem. Res. Toxicol. 2020 33 1323 1327 10.1021/acs.chemrestox.0c00004 32115938
Bensky D. Clavey S. Stõger E. Materia Medica—Chinese Herbal Medicine 3rd ed. Eastland Press Seattle, WA, USA 2004 3 6
Mudie D.M. Murray K. Hoad C.L. Pritchard S.E. Garnett M.C. Amidon G.L. Gowland P.A. Spiller R.C. Amidon G.E. Marciani L. Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State Mol. Pharm. 2014 11 3039 3047 10.1021/mp500210c 25115349
